The formation of the anterior and intermediate lobes of the pituitary gland is a multi-step process regulated by cell-cell interactions involving a number of signaling pathways and by cascades of cell-intrinsic transcription factors. The LIM-homeodoamin protein Lhx3 has previously been shown to play an essential role in the growth of Rathke's pouch, a primordium of the anterior and intermediate lobes of the pituitary. However, the mechanisms underlying the function and regulation of Lhx3 remain to be elucidated. Here we report that a targeted insertion of a DNA fragment in the 3 0 -untranslated region of the Lhx3 gene reduces the expression of both Lhx3 mRNA and protein in Rathke's pouch. Mutant mice homozygous for this Lhx3 allele show severe hypoplasia of the pouch, a defect identical to that observed in Lhx3-null mutants. To gain insights into the mechanism of Lhx3 function in pituitary development, we further analyzed the Lhx3 deficient mutants by examination of early pituitary marker expression, cell proliferation, and cell apoptosis. Our results revealed an increase in cell apoptosis and a loss of Islet1 and Calbindin marker expression in Rathke's pouch of these mutants. Recently, increased cell apoptosis in Rathke's pouch has been described in mutant mice impaired in the function of the bicoid-like homeodomain proteins Pitx1 and Pitx2. In those mutants, the expression of Lhx3 is absent. Our results thus underscore the view that Lhx3 functions downstream of the Pitx factors in the same transcriptional cascade that controls growth and early cell differentiation of the developing pituitary gland. Published by Elsevier Ireland Ltd.
Introduction
The pituitary gland plays important roles in the regulation of growth, metabolism, and reproduction by secreting various types of hormones in response to signals from the brain. A mature pituitary gland is comprised of three lobes that arise from different progenitor domains during embryonic development. The posterior lobe of the pituitary, which contains mostly axon terminals that are projected from the hypothalamus, is derived from neural ectoderm of the ventral diencephalon, whereas the anterior and intermediate lobes, sites of the various types of hormone-producing endocrine cells, are derived from a midline invagination of the oral ectoderm known as Rathke's pouch.
Development of the anterior and intermediate lobes of the pituitary is a multi-stage process involving early tissue patterning and subsequent cell lineage specification, proliferation, and differentiation. Recent studies indicate that this process is precisely regulated by cell-cell interactions that are mediated by signaling molecules, and by cell-intrinsic transcription factors (for reviews, see Dasen and Rosenfeld, 2001; Savage et al., 2003; Sheng and Westphal, 1999) .
Signaling molecules, including the fibroblast growth factor FGF8 and the bone morphogenetic protein BMP4, are expressed in the ventral diencephalon abutting the dorsal region of the developing pouch. The BMP2 and Sonic hedgehog (Shh) proteins are expressed in the mesenchymal or oral ectodermal cells, respectively, adjacent to the ventral region of the developing pouch. These signaling molecules play critical roles in the regulation of proliferation and specification of the progenitor cells at multiple steps of pituitary development (Ericson et al., 1998; Norlin et al., 2000; Takuma et al., 1998; Treier et al., 1998 Treier et al., , 2001 ). In addition, the signaling molecules Wnt4 and Wnt5A are expressed either in the developing pouch or in the adjacent ventral diencephalon (Treier et al., 1998) . These molecules are involved, respectively, in the regulation of cell lineage expansion and the shape of the pituitary during development (Cha et al., 2004; Treier et al., 1998) .
Development of the pituitary is also regulated by the stepwise activation of a number of transcription factors. Examples are the POU domain-containing transcription factor Pit1 and its upstream regulator, the paired-like homeodomain factor Prop1, that are required for the determination and differentiation of the somatotrope, lactotrope, and thyrotrope cell lineages in the pituitary (Camper et al., 1990; Li et al., 1990; Nasonkin et al., 2004; Sornson et al., 1996; Ward et al., 2005) . The T-box transcription factor Tpit plays a dual role in later cell lineage differentiation. It promotes the differentiation of the corticotropes and melanotropes while it represses the differentiation of the gonadotropes and thyrotropes in the developing pituitary (Pulichino et al., 2003) . The two closely related bicoid-like homeodomain proteins Pitx1 and Pitx2 are required, in a functionally redundant and dosagedependent manner, for the growth of Rathke's pouch and for the proper specification or expansion of several cell lineages of the anterior pituitary including the gonadotropes, somatotropes, and thyrotropes (Charles et al., 2005; Gage et al., 1999; Suh et al., 2002) .
Lhx3 and Lhx4 are two closely related LIM-homeodomain transcription factors that are expressed in the developing pituitary. Previous knockout studies have shown that mice with null mutations in both Lhx3 and Lhx4 fail to form a definitive Rathke's pouch (Sheng et al., 1997) . In mutant mice lacking only Lhx3 function, the pouch forms initially but fails to expand and to give rise to a large spectrum of the pituitary endocrine cell lineages (Sheng et al., 1996) . These studies show that Lhx3 and Lhx4 play essential roles in early pituitary development. However, the cause for the growth arrest of Rathke's pouch in Lhx3 mutants has remained unclear. Also, there is a need to define at what stage of development the differentiation of the various pituitary cell lineages is impaired in the Lhx3 mutants. These issues need to be addressed in an effort to gain insights into the mechanisms underlying the function of Lhx3 in pituitary development.
In the present study we report that a targeted insertion of a DNA fragment at the 3 0 -untranslated region (3 0 -UTR) of the Lhx3 gene can significantly reduce the expression of Lhx3 mRNA and protein in Rathke's pouch. Mice homozygous for this allele show severe pituitary hypoplasia, a defect identical to that observed previously in Lhx3-null mutants (Sheng et al., 1996) . To better define the role of Lhx3 in pituitary development, we performed a more extensive analysis of the Lhx3-deficient mutants. Our study revealed an increase in cell apoptosis and a lack of Calbindin and Islet1 expression in the early developing pituitary in the Lhx3
Cre/Cre mutants. These findings are novel as they more specifically define the role of Lhx3 in pituitary development as compared to the previous study of the Lhx3 knockout mutants. An increase in cell apoptosis in Rathke's pouch has recently been observed in Pitx1/2 deficient mice, which also lack the expression of Lhx3 (Charles et al., 2005) . Our results thus support the notion that Lhx3 plays a crucial role downstream of the Pitx genes in a transcriptional cascade controlling survival and early lineage differentiation of cells in Rathke's pouch.
Results

Defects in pituitary development of Lhx3
Cre/Cre mutants
A Lhx3
Cre mutant allele has previously been generated by inserting a fragment that contains an internal ribosome entry site (IRES), a cDNA encoding the Cre recombinase (Cre), and a neomycin resistance gene (Neo) into the 3 0 -UTR of the Lhx3 gene . Given the importance of Lhx3 for the development of the pituitary (Sheng et al., 1996 (Sheng et al., , 1997 , we assessed whether the insertion of the IRES-Cre-Neo fragment affects pituitary morphogenesis. The morphology of the anterior, intermediate, and posterior lobes of the pituitary appeared normal in Lhx3 +/Cre embryos examined at embryonic day (E) 15.5 as compared to wild-type controls ( Fig. 1A and C) . In Lhx3
Cre/Cre embryos, the posterior lobe of the pituitary appeared normal whereas the anterior lobe was largely missing, and the intermediate lobe was reduced in size (Fig. 1B) . These defects of the pituitary are identical to those observed previously in Lhx3-null (Lhx3 À/À ) mutant embryos ( Fig. 1D ; Sheng et al., 1996) .
The previous study of Lhx3 À/À mutants has shown that Rathke's pouch initially forms, but then fails to develop further and to give rise to the various hormone-producing cell lineages (Sheng et al., 1996) . To determine whether Lhx3
Cre/Cre mutants are similarly affected, we examined the mutants at early stages of pituitary development. At E11.5, Rathke's pouch of Lhx3
Cre/Cre mutants ( Fig. 1F ) resembled that of wild-type (Fig. 1E) embryos. By E12.5, the pouch in wild-type embryos had expanded significantly, especially in its anterior and ventral portions (Fig. 1G ). By contrast, the pouch in Lhx3
Cre/Cre mutants failed to expand and to develop further (Fig. 1H ). Thus the defect in the development of the pituitary in Lhx3
Cre/Cre mutants resembles that observed earlier in the Lhx3 À/À null mutants (Sheng et al., 1996) .
Reduced expression of Lhx3 mRNA and protein in Lhx3
The similarity of the pituitary phenotypes observed in Lhx3
Cre/Cre and Lhx3 À/À mutants suggested a defect in expression of normal Lhx3 gene products in Lhx3
Cre/Cre mutant embryos. The Lhx3 Cre/Cre mutants contain an IRES-Cre-Neo fragment inserted into the 3 0 -UTR of the Lhx3 via a 5 0 -homologous sequence containing exons 5, 6, and 7 of the gene . This sequence encodes the homeodomain and C-terminus of the Lhx3 protein. One may argue that mutations in this region occurred during construction of the targeting vector and were subsequently introduced into the Lhx3 locus after homologous recombination. To rule out such a possibility, we sequenced a PCR amplified fragment from this region Cre/Cre mutants (F) like in wild-type controls (E) at E11.5. At E12.5, however, the pouch fails to expand further in the mutant embryos (H) as compared the controls (G). PL, posterior lobe of the pituitary. Bar in H represents 200 lm for panels A-D and 100 lm for panels E-H.
of the Lhx3
Cre allele. No mutations were observed in this region (data not shown).
We next examined expression of Lhx3 mRNA in the heads of the Lhx3
Cre/Cre , Lhx3 +/Cre , and wild-type control embryos by Northern blot analysis (Fig. 2) . A single Lhx3 transcript of about 2.4 kb was detected in E11.5 wild-type embryos. The normal Lhx3 transcript was completely missing in Lhx3
Cre/Cre mutants. Instead, these embryos contained a large transcript of about 5.5 kb, resulting from insertion of the IRES-Cre-Neo fragment. This large transcript, however, was expressed at a level significantly lower than that of the normal transcript in wild-type embryos. In Lhx3 +/Cre embryos, both the normal and the mutant Lhx3 transcripts were expressed, respectively, at about one half the levels observed in wild-type or Lhx3
Cre/Cre mutant embryos. To analyze whether the large transcript from the Lhx3
Cre allele contains the entire Lhx3 coding sequence, we performed RT-PCR using RNA from the Lhx3
Cre/Cre mutant embryos. We were able to amplify a single fragment with a predicted size covering the Lhx3 coding region. By cloning and sequencing this fragment we confirmed that it contained the entire Lhx3 coding sequence (data not shown).
To determine the effect of the IRES-Cre-Neo insertion on expression of Lhx3 protein in the pituitary, we performed immunohistochmical staining using an antibody directed specifically against Lhx3. Lhx3 protein was expressed abundantly in Rathke's pouch in E11.5 and E12.5 wild-type embryos ( Fig. 3A and G) . At E15.5, the expression of Lhx3 protein persisted after the pouch developed into the anterior and intermediate lobes of the pituitary (Fig. 3J) . At all these stages, the expression of Lhx3 protein in the pouch of the Lhx3
Cre/Cre mutants was severely reduced to a barely detectable level (Fig. 3B, I , L). Interestingly, Lhx3 was readily detected in some cells in other Lhx3 expressing regions of the mutant embryos such as the spinal cord and hindbrain (Fig. 3C-F (Fig. 3N ), Lhx3 protein was completely absent in the remnant of Rathke's pouch. These analyses indicate that the insertion of the IRES-Cre-Neo fragment into the 3 0 -UTR of the Lhx3 gene results in a severe reduction in the expression of Lhx3 in the developing pituitary and causes defects in pituitary development identical to that observed in Lhx3-null mutants.
Despite the reduction in Lhx3 expression from the Lhx3
Cre allele, the Cre recombinase appeared to be expressed in the pituitary from the inserted Cre gene. As shown by X-gal staining, the recombination activity of Cre was detected in pituitary cells of embryos carrying both the Lhx3
Cre allele and a R26R reporter allele (Fig. 3O ).
Occurrence of cell proliferation in the developing pituitary of Lhx3
To determine whether the growth arrest of Rathke's pouch in Lhx3 deficient mutants results from impaired cell proliferation, we performed assays using 5-bromo-2 0 -deoxyuridine (BrdU) to label the cells undergoing active proliferation. At E11.5, BrdU labeled many cells in Rathke's pouch, especially those in the dorsal portion of the pouch, both in control (Fig. 4A ) and in Lhx3
Cre/Cre mutant (Fig. 4B) embryos. At E12.5, Rathke's pouch grew larger in control embryos and remained small in Lhx3
Cre/Cre mutant embryos, yet many cells lining the lumen of the pouch were positively labeled by BrdU in both control (Fig. 4C) and mutant (Fig. 4D) embryos. Thus the complete growth arrest of Rathke's pouch in Lhx3 deficient mutants is unlikely to be caused by a defect in proliferation of the cells in the pouch.
Increased cell apoptosis in the developing pituitary of Lhx3
We performed TUNEL staining to determine whether there is an increase in cell apoptosis that may cause failure of Rathke's pouch to expand in Lhx3 deficient mutants. At both E11.5 and E12.5, a larger number of TUNEL positive cells were detected in the ventral portion of Rathke's pouch in Lhx3
Cre/Cre mutant embryos ( Fig. 5B and D) . By contrast, no TUNEL positive cells were detected in Rathke's pouch in wild-type control embryos ( Fig. 5A and C) . These results support the notion that the growth arrest of Rathke's pouch in Lhx3 deficient mutants results primarily from an increase in apoptosis of the cells in the pouch.
Expression of early pituitary marker genes in Lhx3
To determine whether the increased apoptosis of cells in Rathke's pouch in Lhx3 deficient mutants is coupled with defects in the generation of differentiated cell types in the pituitary, we analyzed expression of several early pituitary marker genes in E11.5 or E12.5 embryos by immunohistochemistry. Pitx1 and Pitx2 are two homeobox genes that are extensively expressed and are required for the expansion of Rathke's pouch in early pituitary development (Charles et al., 2005; Suh et al., 2002) . Immunostaining of Pitx1 and Pitx2 was not affected in Lhx3
Cre/Cre mutants ( Fig. 6B and D) when compared to wild-type ( Fig. 6A and C) embryos. This is consistent with a recent report indicating that Pitx1 and Pitx2 may act upstream of Lhx3 (Charles et al., 2005) . In contrast, staining of Calbindin and Islet1, two markers expressed in early differentiated pituitary cells in the ventral region of Rathke's pouch ( Fig. 6E and G ; Ericson et al., 1998) , was missing in Lhx3
Cre/Cre mutants ( Fig. 6F and H) . Thus, the early differentiated pituitary cells are not generated in Lhx3 deficient mutants.
Discussion
Our studies have revealed that a targeted insertion of a DNA fragment (IRES-Cre-Neo) at the 3 0 -UTR of the Lhx3 gene significantly reduces the level of expression of Lhx3 mRNA and protein in the developing pituitary. Mice homozygous for this Lhx3 allele show defects in the development of the pituitary that are identical to those that have 
(+/À) (M) embryos as compared to wild-type (WT) (A, G, J) controls. Lhx3 protein is barely detectable in Lhx3
Cre/Cre (C/C) embryos (B, I, L), and its expression is missing completely in Lhx3 À/À (À/À) (N) embryos. The staining of Lhx3, however, is detected in some cells in the spinal cord (C and D) and hindbrain (E and F) of the Lhx3
Cre/Cre (C/C) mutant embryos (D and F) as compared to wildtype (WT) controls (C and E). By X-gal staining, activity of the Cre recombinase can be detected in the pituitary of embryos carrying both the Lhx3
Cre (+/C) and R26R reporter alleles (O). Analyses were performed at E11.5 (A-F), E12.5 (G-I), or E15.5 (J-O). Bar in O represents 180 lm for panels A and B, 90 lm for panels C-F, and 200 lm for panels G-O. been observed previously in Lhx3-null mutants. In both of these mutants, Rathke's pouch forms initially, but the subsequent expansion of the pouch is impaired, resulting in severe hypoplasia of the anterior and intermediate lobes of the pituitary. More importantly, our present analysis extends previous studies (Sheng et al., 1996 (Sheng et al., , 1997 , and provides new evidence suggesting that the observed defects in the pituitary of Lhx3 mutants result primarily from an increased cell apoptosis and an impairment in early pituitary cell differentiation at more defined stages during the development (Fig. 7) .
In the Lhx3 Cre/Cre mutants, the reduction of expression of the Lhx3
Cre allele appears to be specific for the pituitary. Lhx3 protein is still present, albeit at low levels, as indicated by our consistent observation of faint Lhx3 immunostaining (Fig. 3) . Also, in crosses of mice carrying the Lhx3
Cre allele with a reporter line, the activity of the Cre recombinase could be detected in cells that normally express Lhx3, though again at a low level ( Fig. 3O ; Sharma et al., 1998) . This result is consistent with the view that at least some Lhx3 products are produced in Lhx3
Cre/Cre mutants since the Cre gene was placed downstream of the coding region of the Lhx3 gene. However, the similarity of pituitary defects in Lhx3
Cre/Cre and Lhx3-null mutants suggests that the low level of Lhx3 protein present in Lhx3
Cre/Cre mutants is not sufficient to rescue or even alleviate the phenotype. On the other hand, the development of the pituitary is completely normal in Lhx3 +/À mutants ( Fig. 3M ; Sheng et al., 1996) . These results thus suggest that there is a threshold level required for proper Lhx3 Cre/Cre mutant (B and D) and wild-type control (A and C) embryos, although the pouch in Lhx3
Cre/Cre mutant embryos at E12.5 is smaller than that in the controls. Bar in (D) represents 100 lm for all panels. function in pituitary development. Alternatively, the insertion of the IRES-Cre-Neo fragment into the Lhx3 locus may cause aberrant splicing of the Lhx3 transcripts giving rise to non-functional Lhx3 products, and hence to the observed pituitary phenotype of the Lhx3
Cre/Cre mutants. Our early study showed that a knockout of the Lhx3 gene results in a loss of a majority of the pituitary endocrine cell lineages with the exception of a few remaining POMC-positive corticotroph cells (Sheng et al., 1996) . Results from our present study show Lhx3 is required for maintaining the viability and differentiation of cells in the ventral region of the Rathke's pouch. A deficiency of Lhx3 protein causes these cells to undergo apoptosis and fail to differentiate into Calbindin-or Islet1-expressing cells (Fig. 6) . Analogous defects in cell differentiation have been observed in the spinal cord in mice deficient in the function of Islet1. In these mutants, motor neuron progenitor cells fail to differentiate properly and undergo apoptosis (Pfaff et al., 1996) . It remains to be determined whether the same holds for the cells in the developing pituitary of the Lhx3 mutants or whether Lhx3 is primarily a survival factor guiding the cells through the process of differentiation. Cre/Cre mutants. At E11.5, Pitx1 (A and B) and Pitx2 (C and D) are both detected in Rathke's pouch in Lhx3
Cre/Cre mutant (B and D) and control embryos (A and C). At E12.5, the cells in the anterior-ventral area of the pouch are labeled by staining of Calbindin (E) and Islet1 (G) in control embryos (arrowheads). These cells are missing in Lhx3
Cre/Cre mutant embryos (F and H). Bar in (H) represents 100 lm for all panels. Lhx3 and Pitx1/2 mutants very much resemble each other in their phenotypic defects of pituitary development (Charles et al., 2005; Gage et al., 1999; Suh et al., 2002) , suggesting that Lhx3 and Pitx1/2 genes are part of a common regulatory cascade. Pitx1 and Pitx2 are required, in a redundant manner, for the expression of Lhx3 in Rathke's pouch, indicating that the Pitx genes serve as positive regulators upstream of Lhx3 (Charles et al., 2005) . This is consistent with our observation that both Pitx1 and Pitx2 are normally expressed in the pouch of Lhx3 mutants (Fig. 7) . The Pitx genes are essential for cell survival in the developing pouch (Charles et al., 2005) , and we show that the same holds for Lhx3. Our study thus provides additional evidence in support of the notion that Lhx3 acts downstream of Pitx1/2 in the same cascade controlling development of the pituitary.
Experimental procedures
Mouse breeding and genotyping
The generation of Lhx3 +/À and Lhx3 +/Cre mice has been described previously (Sheng et al., 1996; Sharma et al., 1998) . To obtain homozygous mutant embryos for analysis, the heterozygous parents were mated and checked daily for presence of plugs. Noon of the day when a plug was detected was designated as E0.5. Mouse genotypes were determined by PCR analysis using primers as follows: primers for genotyping offspring from crossing between 
Histology and immunohistochemistry
Embryos were collected at various developmental stages and fixed in 4% paraformaldehyde in 0.1 M sodium phosphate buffer (pH 7.4) at 4°C overnight. After several washes in phosphate buffered saline (PBS), the embryos were dehydrated in ethanol, embedded in paraffin, and sectioned at a thickness of 5 lm. For histological analysis, the sections were stained with standard procedures in hematoxylin and eosin (H and E) (Sigma). For immunohistochemistry, the sections were treated to retrieve epitopes by boiling in an antigen unmasking solution (Vector Laboratory, for anti-Lhx3, Islet1, Pitx1, and Pitx2 staining) or incubation in trypsin (Sigma, 0.1% in PBS, 15 minutes at 37°C, for anti-Calbindin staining). The antibodies used are as follows: mouse anti-Lhx3 (1:400) and anti-Islet1 (1:600) (Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA, USA), rabbit anti-Pitx1 (1:80) and anti-Pitx2 (1:4) (kindly provided by Dr. Jacques Drouin, Institut de Recherche Cliniques de Montreal, Montreal Quebec, Canada, and Dr. Jeffrey Murray, University of Iowa, Iowa City, IA, USA, respectively), rabbit anti-Calbindin (1:1000, Chemicon). Immunostaining was performed using an ABC elite kit (for rabbit antibodies) or a M.O.M kit (for mouse antibodies) by following procedures suggested by the manufacturer (Vector Laboratory). To ensure fair comparison of each antibody staining, sections from embryos of various genotypes were processed simultaneously.
Assays for cell proliferation and cell apoptosis
For labeling the cells undergoing proliferation, pregnant females were injected intraperitoneally with BrdU (Sigma, 100 lg/gram of body weight, dissolved in saline) and sacrificed 1 hour later. Embryos were dissected, processed, and sectioned as described above. BrdU was detected with a peroxidase labeled anti-BrdU antibody (Roche) on sections treated with HCl (2 M) and sodium borate by following previously described procedures (Zhao et al., 1999) . For detection of cell apoptosis, TUNEL staining was performed using an APO-BrdU-IHC kit (Chemicon) by following the manufacturer's instruction.
Analysis of recombination activity of the Cre recombinase
The activity of Cre recombinase in the pituitary was analyzed by crossing the Lhx3 +/Cre mice to a R26R reporter strain (B6;129-Gt(ROSA)26-Sor tm1Sho /J, Jackson Laboratory) that contains a LoxP flanked stop codon upstream of a LacZ gene at the Rosa26 locus. The LacZ is expressed upon removal of the stop codon after Cre-mediated recombination between the LoxP sites. To detect LacZ expression, fresh frozen sagittal sections through the pituitary were cut from E15.5 embryos. The sections were fixed briefly in 2% paraformaldehyde/0.2% gluteraldehyde and processed for X-gal staining by following published procedures (Sanes et al., 1986) .
Northern blot analysis
Total RNA was purified from E11.5 mouse embryos with TriPure RNA isolation reagent (Roche). For each genotype, 18 lg of the RNA was loaded and separated on an agarose gel with electrophoresis. The RNA was transferred to a nylon membrane and hybridized with a Lhx3-specific probe in ExpressHyb solution (BD bioscience), following the manufacturer's protocol. The Lhx3 probe was a 212 bp cDNA fragment generated by RT-PCR using total RNA from an E11.5 mouse embryo as a template. The primer set specific for Lhx3 used for amplification was: forward primer, 5 0 -ACTGCAAAGACGACTTC; reverse primer, 5 0 -TGTTTCGTAGTCCGCC. To check for equal loading and transfer of the RNA samples, the blot was re-hybridized with a probe specific for the ubiquitously expressed b-actin gene.
PCR, RT-PCR, and sequence analysis of Lhx3
Cre allele and transcript To sequence part of the Lhx3
Cre allele, genomic DNA from the Lhx3
Cre/Cre mutant embryos was prepared and used as a template to amplify a 2 kb fragment between exon3 and exon5 of the Lhx3 gene using an Expand Long Template PCR Kit (Roche). The primers used for PCR were: Lhx3s-1, 5 0 -TACGAAACAGCCAAGCAGCGAGGTCA; Lhx3a, 5 0 -TCAGAGGTCCTTGGAATGGACAGCA. For RT-PCR, cDNA was synthesized from total RNA of E11.5 Lhx3
Cre/Cre mutant heads using an iScript Select cDNA synthesis Kit (Bio-Rad). The cDNA was amplified using Lhx3a and Lhx3s-5 0 (5 0 -AGGCCTGAAAGAGGTCCAGCACT) primers that flank the entire Lhx3 coding region. The amplified fragment was cloned into the pGEM-TEasy vector (Promega) and then sequenced.
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